West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析

◆英語タイトル:West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1677FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

West Pharmaceutical Services Inc (WST) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company’s major products include containment solutions, primary packaging, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves generic, biologic, pharmaceutical, diagnostic and medical device companies across the world. The company distributes its products and services directly and also through a network of distributors worldwide. It has presence in North and South America, Europe, Asia and Australia. West Pharmaceutical is headquartered in Exton, Pennsylvania, the US.

West Pharmaceutical Services Inc Key Recent Developments

Feb 18,2021: West announces fourth-quarter and full-year 2020 results
Nov 09,2020: West appoints Kimberly Banks MacKay as Senior VicePresident General Counsel and Corporate Secretary
Oct 22,2020: West announces third-quarter 2020 results
Apr 23,2020: West announces first-quarter 2020 results
Feb 17,2020: West appoints new Director to the Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
West Pharmaceutical Services Inc – Key Facts
West Pharmaceutical Services Inc – Key Employees
West Pharmaceutical Services Inc – Key Employee Biographies
West Pharmaceutical Services Inc – Major Products and Services
West Pharmaceutical Services Inc – History
West Pharmaceutical Services Inc – Company Statement
West Pharmaceutical Services Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
West Pharmaceutical Services Inc – Business Description
Business Segment: Contract-Manufactured Products
Overview
Performance
Business Segment: Proprietary Products
Overview
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Other
Performance
Geographical Segment: Other European Countries
Performance
Geographical Segment: The US
Performance
R&D Overview
West Pharmaceutical Services Inc – Corporate Strategy
West Pharmaceutical Services Inc – SWOT Analysis
SWOT Analysis – Overview
West Pharmaceutical Services Inc – Strengths
West Pharmaceutical Services Inc – Weaknesses
West Pharmaceutical Services Inc – Opportunities
West Pharmaceutical Services Inc – Threats
West Pharmaceutical Services Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
West Pharmaceutical Services Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
West Pharmaceutical Services Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: West announces fourth-quarter and full-year 2020 results
Nov 09, 2020: West appoints Kimberly Banks MacKay as Senior VicePresident General Counsel and Corporate Secretary
Oct 22, 2020: West announces third-quarter 2020 results
Apr 23, 2020: West announces first-quarter 2020 results
Feb 17, 2020: West appoints new Director to the Board
Feb 13, 2020: West announces fourth-quarter and full-year 2019 results
Feb 05, 2020: West launches new product innovations at Pharmapack 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
West Pharmaceutical Services Inc, Key Facts
West Pharmaceutical Services Inc, Key Employees
West Pharmaceutical Services Inc, Key Employee Biographies
West Pharmaceutical Services Inc, Major Products and Services
West Pharmaceutical Services Inc, History
West Pharmaceutical Services Inc, Subsidiaries
West Pharmaceutical Services Inc, Key Competitors
West Pharmaceutical Services Inc, Ratios based on current share price
West Pharmaceutical Services Inc, Annual Ratios
West Pharmaceutical Services Inc, Annual Ratios (Cont...1)
West Pharmaceutical Services Inc, Annual Ratios (Cont...2)
West Pharmaceutical Services Inc, Interim Ratios
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
West Pharmaceutical Services Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
West Pharmaceutical Services Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野:企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Brookfield Renewable Energy Partners LP (BEP.UN):電力:M&Aディール及び事業提携情報
    Summary Brookfield Renewable Energy Partners LP (Brookfield Renewable) formerly Brookfield Renewable Energy Partners, L.P. is a renewable power company. It is a wholly owned subsidiary of Brookfield Asset Management Inc. It owns, operates and develops renewable power generation facilities across Nor …
  • Co.don AG (CNWK):企業の財務・戦略的SWOT分析
    Summary Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biologica …
  • Green Highland Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary Green Highland Renewables Ltd (GHRL), formerly Green Highlander Renewables Limited, a subsidiary of Ancala Partners LLP, is a renewable energy company that develops, builds, and maintains hydro electric schemes. The company provides services including site identification, environmental appra …
  • Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the …
  • Saipem SpA (SPM)-石油・ガス分野:企業M&A・提携分析
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • SARIA AS GmbH & Co KG:企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • AMETEK Inc (AME):企業の財務・戦略的SWOT分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturer. The company manufactures electronic instruments and electromechanical devices. Its product portfolio includes medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys a …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sublimity Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sublimity Therapeutics Ltd(Sublimity) formerly known as Sigmoid Pharma Ltd, focuses on the development of therapeutics for unmet clinical needs in gastrointestinal and immunological diseases and disorders. The company’s product portfolio includes cyclosporine, oral vaccines, oral peptides an …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Caribbean Utilities Company, Ltd. (CUP.U):電力:M&Aディール及び事業提携情報
    Summary Caribbean Utilities Company, Ltd. (CUC) is a vertically integrated electricity utility. Through licenses with the Cayman Islands Government, the company generates, transmits, and distributes electricity. It produces electricity from diesel. CUC’s power utility system includes diesel engines, …
  • Outokumpu Oyj:企業の戦略・SWOT・財務情報
    Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report Summary Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Allergy Therapeutics Plc (AGY):製薬・医療:M&Aディール及び事業提携情報
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆